JNJ
Johnson & Johnson · Healthcare · Drug Manufacturers - General
Momentum inputs (comparable managers):
holder breadth +0.5% ·
share flow -0.1% ·
net new positions +1.1%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 183 | +1 | 1.45B | $367.13B | +5 | −3 |
| Q1 2026 | 184 | 0 | 1.43B | $348.29B | +4 | −5 |
| Q4 2025 | 183 | 0 | 1.52B | $314.40B | +2 | −1 |
| Q3 2025 | 28 | 0 | 887.20M | $164.46B | — | −1 |
| Q2 2025 | 26 | +1 | 740.96M | $113.15B | +1 | — |
| Q1 2025 | 22 | -1 | 281.15M | $46.60B | — | −1 |
| Q4 2024 | 23 | +3 | 290.64M | $42.01B | +3 | — |
| Q3 2024 | 19 | -2 | 157.55M | $25.50B | — | −2 |
| Q2 2024 | 21 | — | 161.11M | $23.53B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 13 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 14 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 15 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 16 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 17 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 18 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 19 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 20 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 21 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 22 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 23 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 24 | BlackRock ✦ (passive) | 212.10M | -0.6% | $53.87B | 0.8% | ▼ Trim | 5 | SEC ↗ |
| 25 | Vanguard Capital Management Llc | 157.23M | +0.4% | $39.93B | 0.9% | ▲ Add | 2 | SEC ↗ |
| 26 | State Street Global Advisors ✦ (passive) | 133.78M | +0.2% | $33.98B | 1.0% | ▲ Add | 7 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 58.30M | -7.6% | $15.07B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 49 | Geode Capital Management ✦ (passive) | 59.09M | -0.1% | $14.97B | 0.8% | ▼ Trim | 9 | SEC ↗ |
| 50 | Geode Capital Management ✦ (passive) | 59.09M | -0.1% | $14.97B | 0.8% | ▼ Trim | 9 | SEC ↗ |
| 51 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 52 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 53 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 54 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 55 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 56 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 57 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 58 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 59 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 60 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 61 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 62 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 63 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 64 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 65 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 66 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 67 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 68 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 69 | Morgan Stanley ✦ | 44.81M | +0.2% | $11.38B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 70 | Norges Bank ✦ (passive) | 31.83M | New | $8.08B | 0.8% | New | 1 | SEC ↗ |
| 71 | State Farm Mutual Automobile… | 31.59M | 0.0% | $8.02B | 5.5% | Held | 3 | SEC ↗ |
| 72 | State Farm Mutual Automobile… | 31.59M | 0.0% | $8.02B | 5.5% | Held | 3 | SEC ↗ |
| 73 | Northern Trust Corp | 28.79M | -1.8% | $7.31B | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 74 | Northern Trust Corp | 28.79M | -1.8% | $7.31B | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 75 | Northern Trust Corp | 28.79M | -1.8% | $7.31B | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 76 | Northern Trust Corp | 28.79M | -1.8% | $7.31B | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 77 | Northern Trust Corp | 28.79M | -1.8% | $7.31B | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 78 | Northern Trust Corp | 28.79M | -1.8% | $7.31B | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 79 | Northern Trust Corp | 28.79M | -1.8% | $7.31B | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 80 | Northern Trust Corp | 28.79M | -1.8% | $7.31B | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 81 | Northern Trust Corp | 28.79M | -1.8% | $7.31B | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 82 | Northern Trust Corp | 28.79M | -1.8% | $7.31B | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 83 | Northern Trust Corp | 28.79M | -1.8% | $7.31B | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 84 | Northern Trust Corp | 28.79M | -1.8% | $7.31B | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 85 | Bank Of America Corp /De/ | 23.44M | -8.2% | $5.95B | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 86 | Bank Of America Corp /De/ | 23.44M | -8.2% | $5.95B | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 87 | Bank Of America Corp /De/ | 23.44M | -8.2% | $5.95B | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 88 | Bank Of America Corp /De/ | 23.44M | -8.2% | $5.95B | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 89 | Bank Of America Corp /De/ | 23.44M | -8.2% | $5.95B | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 90 | Bank Of America Corp /De/ | 23.44M | -8.2% | $5.95B | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 91 | Bank Of America Corp /De/ | 23.44M | -8.2% | $5.95B | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 92 | Bank Of America Corp /De/ | 23.44M | -8.2% | $5.95B | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 93 | T. Rowe Price ✦ | 23.00M | +39.5% | $5.84B | 0.6% | ▲ Add | 9 | SEC ↗ |
| 94 | T. Rowe Price ✦ | 23.00M | +39.5% | $5.84B | 0.6% | ▲ Add | 9 | SEC ↗ |
| 95 | Fidelity (FMR) ✦ | 22.60M | -8.8% | $5.74B | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 96 | Fidelity (FMR) ✦ | 22.60M | -8.8% | $5.74B | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 97 | Fidelity (FMR) ✦ | 22.60M | -8.8% | $5.74B | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 98 | Fidelity (FMR) ✦ | 22.60M | -8.8% | $5.74B | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 99 | Fidelity (FMR) ✦ | 22.60M | -8.8% | $5.74B | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 100 | Fidelity (FMR) ✦ | 22.60M | -8.8% | $5.74B | 0.2% | ▼ Trim | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Norges Bank | $8.08B | 0.8% |
Exited
| Peak6 Llc | $4.54M | was 0.1% |
| Walleye Trading LLC | $905,406 | was 0.0% |
| Optiver Holding B.V. | $247,618 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 136.10K shares, $33,268 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 15.00K sh · $3.95M
Officer, Director · 20.98K sh · $5.50M
Officer, Director · 102.31K sh · $26.70M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug to treat a…
Reuters